Angiodynamics Stock Investor Sentiment

ANGO Stock  USD 5.87  0.16  2.65%   
About 61% of AngioDynamics' investor base is looking to short. The analysis of overall sentiment of trading AngioDynamics stock suggests that many investors are alarmed at this time. AngioDynamics' investor sentiment overview provides quick insight into current market opportunities from investing in AngioDynamics. The current market sentiment, together with AngioDynamics' historical and current headlines, can help investors time the market. In addition, many technical investors use AngioDynamics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
AngioDynamics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of AngioDynamics daily returns and investor perception about the current price of AngioDynamics as well as its diversification or hedging effects on your existing portfolios.
  

AngioDynamics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards AngioDynamics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over two months ago at finance.yahoo.com         
AngioDynamics New XL Catheter to Help in PAD Treatment
Yahoo News
over two months ago at zacks.com         
AngioDynamics New XL Catheter to Help in PAD Treatment
zacks News
over three months ago at businesswire.com         
AngioDynamics Announces FDA 510 Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Ar...
businesswire News
over three months ago at businesswire.com         
AngioDynamics Announces FDA 510 Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Ar...
businesswire News
over three months ago at finance.yahoo.com         
AngioDynamics Announces FDA 510 Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Ar...
Yahoo News
over three months ago at seekingalpha.com         
AngioDynamics gets FDA clearance for Auryon XL catheter
seekingalpha News
over three months ago at kalkinemedia.com         
Varicose Veins Treatment Market Size to Reach 491.09 Million Globally by 2030 Latest Report by Vanta...
news
over three months ago at finance.yahoo.com         
Angiography Catheters Market Size to Hit USD 2.4 billion by 2031, at a 6.3 percent CAGR Report by Tr...
Yahoo News
over three months ago at benzinga.com         
Angiography Catheters Market Size to Hit USD 2.4 billion by 2031, at a 6.3 percent CAGR Report by Tr...
benzinga news
over three months ago at news.google.com         
AngioDynamics Restructuring Initiative May Not Go Far Enough - Seeking Alpha
Google News at Macroaxis
over three months ago at thelincolnianonline.com         
Q3 2024 EPS Estimates for AngioDynamics, Inc. Lowered by Analyst
news
over three months ago at thelincolnianonline.com         
AngioDynamics PT Lowered to 10.00 at Raymond James
news
over three months ago at thelincolnianonline.com         
HC Wainwright Lowers AngioDynamics Price Target to 18.00
news
over three months ago at thelincolnianonline.com         
SANUWAVE Health and AngioDynamics Head to Head Comparison
news
over three months ago at zacks.com         
AngioDynamics Q2 Earnings Top Estimates, Revenues Miss
zacks News
Far too much social signal, news, headlines, and media speculation about AngioDynamics that are available to investors today. That information is available publicly through AngioDynamics media outlets and privately through word of mouth or via AngioDynamics internal channels. However, regardless of the origin, that massive amount of AngioDynamics data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of AngioDynamics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of AngioDynamics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to AngioDynamics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive AngioDynamics alpha.

AngioDynamics Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for 45 Million
02/15/2024
2
Acquisition by Stephen Trowbridge of 1927 shares of AngioDynamics at 4.67 subject to Rule 16b-3
02/29/2024
3
Why AngioDynamics Dipped More Than Broader Market Today
03/08/2024
4
AngioDynamics Q3 2024 Earnings Preview
04/03/2024
5
AngioDynamics Receives 510 Clearance for AlphaVac F1885 System in Treatment of PE
04/04/2024
6
AngioDynamics AlphaVac Gets FDA Nod for PE Treatment
04/05/2024
7
AngioDynamics CEO buys 67,000 worth of company stock
04/08/2024
8
Insider Spends US67k Buying More Shares In AngioDynamics
04/10/2024
9
Acquisition by Helsel Dave of 4371 shares of AngioDynamics subject to Rule 16b-3
04/15/2024
When determining whether AngioDynamics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AngioDynamics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Angiodynamics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Angiodynamics Stock:
Check out AngioDynamics Hype Analysis, AngioDynamics Correlation and AngioDynamics Performance.
To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.
Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics' price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Transaction History
View history of all your transactions and understand their impact on performance
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.80)
Revenue Per Share
8.105
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.05)
Return On Equity
(0.62)
The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AngioDynamics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.